David P. Hochman
2022
In 2022, David P. Hochman earned a total compensation of $3.2M as Chief Executive Officer & Chairman at Orchestra BioMed Holdings.
Compensation breakdown
| Non-Equity Incentive Plan | $395,000 |
|---|---|
| Option Awards | $2,303,394 |
| Salary | $395,000 |
| Stock Awards | $63,000 |
| Total | $3,156,394 |
Hochman received $2.3M in option awards, accounting for 73% of the total pay in 2022.
Hochman also received $395K in non-equity incentive plan, $395K in salary and $63K in stock awards.
Rankings
In 2022, David P. Hochman's compensation ranked 1,150th out of 5,736 executives tracked by ExecPay. In other words, Hochman earned more than 80.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,150 out of 5,736 | 80th |
Division Manufacturing | 554 out of 3,125 | 82nd |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 63 out of 485 | 87th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 42 out of 347 | 88th |
Industry Surgical and Medical Instruments and Apparatus | 33 out of 253 | 87th |
Source: SEC filing on April 30, 2024.
Hochman's colleagues
We found one more compensation record of an executive who worked with David P. Hochman at Orchestra BioMed Holdings in 2022.
2022
Darren Sherman
Orchestra BioMed Holdings